查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2153442

2026-2034年全球無導管胰島素幫浦市場規模、佔有率、趨勢和成長分析報告

Global Tubeless Insulin Pump Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 258 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球無導管胰島素幫浦市場預計將從2025年的26.4億美元成長至2034年的130.1億美元，2026年至2034年的複合年成長率（CAGR）為19.39%。隨著穿戴式科技（旨在為糖尿病管理提供便利、持續的胰島素輸注）的日益普及，該市場正受到越來越多的關注。無導管胰島素幫浦無需傳統幫浦系統所需的外部導管，即可在一個緊湊的設備中輸送胰島素。這些設備有助於合格的患者更好地管理胰島素輸注，同時減少導管帶來的實際不便。人們對糖尿病管理方案的認知不斷提高、穿戴式醫療技術的進步以及對個人化醫療日益成長的興趣，都在推動市場需求。一些系統配備的自動胰島素輸注功能也吸引了患者和醫療專業人員的注意。

市場成長的促進因素包括糖尿病管理需求的不斷成長、胰島素輸注技術的進步以及血糖監測系統的改進。與串聯血糖監測儀整合後，相容設備能夠利用血糖值測量值和控制演算法來調整胰島素劑量。製造商正致力於小型化、改進黏附系統、智慧型手機連接以及方便用戶使用型介面。不斷擴大的糖尿病教育課程和更便利的專科護理服務也有助於患者了解可用的治療方案。此外，醫療專業人員在選擇合適的胰島素輸注系統時，也越來越重視患者的個人偏好、生活方式需求和治療目標。

該市場的未來前景將受到自動化胰島素輸注技術、穿戴式裝置設計以及與數位健康平台整合等方面的進步的影響。改進的演算法有望使兼容系統更有效地應對血糖值波動和個別胰島素需求。製造商也可能致力於延長設備佩戴時間、提高舒適度以及簡化設定和監控。然而，價格、保險報銷政策、設備可靠性、皮膚刺激以及培訓要求等因素可能會影響其普及。隨著系統自動化程度的提高，監管和臨床證據仍然至關重要。持續的創新和糖尿病相關技術的普及有望進一步推動市場成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為特定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別未來預期趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，以更好地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球無導管胰島素幫浦市場：按類型分類

  • 市場分析、洞察與預測
  • 胰島素貼片幫浦
  • 傳統泵浦

第5章 全球無導管胰島素幫浦市場：依組件分類

  • 市場分析、洞察與預測
  • 膠囊或貼片
  • 偏僻的
  • 配件

第6章：全球無導管胰島素幫浦市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 藥局
  • 電子商務

第7章 全球無導管胰島素幫浦市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 中國
    • 日本
    • 韓國
    • 印度
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Insulet
    • Tandem Diabetes Care
    • Medtronic
    • Roche
    • EOFlow
    • SFC Fluidics
    • CeQur
    • Beta Bionics
    • Diabeloop
    • Kaleido
    • Mylife YpsoPump
    • Sequel Med Tech
    • Medtrum
    • Sooil Development
    • MicroPort
    • Terumo
    • Debiotech
    • Bigfoot Biomedical
    • Senseonics
    • Abbott
簡介目錄
Product Code: VMR11216458

The global tubeless insulin pump market size is expected to reach USD 13.01 Billion in 2034 from USD 2.64 Billion in 2025, growing at a CAGR of 19.39% during 2026-2034.This market is gaining attention as diabetes management increasingly incorporates wearable technologies designed to deliver insulin conveniently and continuously. Tubeless insulin pumps use compact devices that deliver insulin without the conventional external tubing associated with traditional pump systems. These devices can help eligible patients manage insulin administration while reducing some practical limitations associated with connected tubing. Growing awareness of diabetes management options, improvements in wearable medical technology, and increasing interest in personalized care are supporting demand. The availability of automated insulin delivery features in certain systems is also attracting attention among patients and healthcare professionals.

Market growth is driven by the rising need for diabetes management, advancements in insulin delivery technology, and improvements in glucose monitoring systems. Integration with continuous glucose monitors can enable compatible devices to adjust insulin delivery using glucose readings and control algorithms. Manufacturers are investing in smaller designs, improved adhesive systems, smartphone connectivity, and user-friendly interfaces. Expanding diabetes education programs and greater access to specialist care are also helping patients understand available treatment options. In addition, healthcare providers are increasingly considering individual preferences, lifestyle requirements, and treatment goals when selecting suitable insulin delivery systems.

The future prospects of this market will be shaped by advances in automated insulin delivery, wearable device design, and integration with digital health platforms. Improvements in algorithms may help compatible systems respond more effectively to changing glucose levels and individual insulin requirements. Manufacturers may also focus on extending device wear time, improving comfort, and simplifying setup and monitoring. However, affordability, reimbursement policies, device reliability, skin irritation, and training requirements may influence adoption. Regulatory oversight and clinical evidence will remain important as systems become more automated. Continued innovation and broader access to diabetes technology could support further market expansion.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Type

  • Insulin patch pump
  • Traditional pump

By Component

  • Pod or Patch
  • Remote
  • Accessories

By End Users

  • Hospitals
  • Pharmacies
  • E-commerce

COMPANIES PROFILED

  • Insulet, Tandem Diabetes Care, Medtronic, Roche, EOFlow, SFC Fluidics, CeQur, Beta Bionics, Diabeloop, Kaleido, Mylife YpsoPump, Sequel Med Tech, Medtrum, Sooil Development, MicroPort, Terumo, Debiotech, Bigfoot Biomedical, Senseonics, Abbott

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL TUBELESS INSULIN PUMP MARKET: BY TYPE 2022-2034 (USD MN and K Units)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Insulin patch pump Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 4.3. Traditional pump Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 5. GLOBAL TUBELESS INSULIN PUMP MARKET: BY COMPONENT 2022-2034 (USD MN and K Units)

  • 5.1. Market Analysis, Insights and Forecast Component
  • 5.2. Pod or Patch Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 5.3. Remote Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 5.4. Accessories Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 6. GLOBAL TUBELESS INSULIN PUMP MARKET: BY END USERS 2022-2034 (USD MN and K Units)

  • 6.1. Market Analysis, Insights and Forecast End Users
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 6.3. Pharmacies Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)
  • 6.4. E-commerce Estimates and Forecasts By Regions 2022-2034 (USD MN and K Units)

Chapter 7. GLOBAL TUBELESS INSULIN PUMP MARKET: BY REGION 2022-2034 (USD MN and K Units)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 7.2.1 By Type
    • 7.2.2 By Component
    • 7.2.3 By End Users
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 7.3.1 By Type
    • 7.3.2 By Component
    • 7.3.3 By End Users
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Spain
    • 7.3.9 Russia
    • 7.3.10 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 7.4.1 By Type
    • 7.4.2 By Component
    • 7.4.3 By End Users
    • 7.4.4 China
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 India
    • 7.4.8 Australia
    • 7.4.9 South East Asia
    • 7.4.10 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 7.5.1 By Type
    • 7.5.2 By Component
    • 7.5.3 By End Users
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and K Units)
    • 7.6.1 By Type
    • 7.6.2 By Component
    • 7.6.3 By End Users
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL TUBELESS INSULIN PUMP INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Insulet
    • 9.2.2 Tandem Diabetes Care
    • 9.2.3 Medtronic
    • 9.2.4 Roche
    • 9.2.5 EOFlow
    • 9.2.6 SFC Fluidics
    • 9.2.7 CeQur
    • 9.2.8 Beta Bionics
    • 9.2.9 Diabeloop
    • 9.2.10 Kaleido
    • 9.2.11 Mylife YpsoPump
    • 9.2.12 Sequel Med Tech
    • 9.2.13 Medtrum
    • 9.2.14 Sooil Development
    • 9.2.15 MicroPort
    • 9.2.16 Terumo
    • 9.2.17 Debiotech
    • 9.2.18 Bigfoot Biomedical
    • 9.2.19 Senseonics
    • 9.2.20 Abbott